Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block

J Clin Anesth. 2016 Sep:33:14-9. doi: 10.1016/j.jclinane.2016.01.015. Epub 2016 Apr 6.

Abstract

Study objective: The aim of this study was to evaluate the efficacy of sugammadex in reversing profound rocuronium-induced neuromuscular block at the laryngeal adductor muscles using motor-evoked potentials (mMEPs).

Design: A prospective observational study.

Setting: University surgical center.

Patients: Twenty patients with American Society of Anesthesiologists physical class I-II status who underwent propofol-remifentanil anesthesia for the surgery of the thyroid gland.

Interventions: Patients were enrolled for reversal of profound neuromuscular block (sugammadex 16 mg/kg, 3 minutes after rocuronium 1.2 mg/kg). To prevent laryngeal nerve injury during the surgical procedures, all patients underwent neurophysiologic monitoring using mMEPs from vocal muscles. At the same time, the registration of TOF-Watch acceleromyograph at the adductor pollicis muscle response to ulnar nerve stimulation was performed; recovery was defined as a train-of-four (TOF) ratio ≥0.9.

Measurement and main results: After injection of 16 mg/kg of sugammadex, the mean time to recovery of the basal mMEPs response at the laryngeal adductor muscles was 70 ± 18.2 seconds. The mean time to recovery of the TOF ratio to 0.9 was 118 ± 80 seconds. In the postoperative period, 12 patients received follow-up evaluation of the vocal cords and no lesions caused by the surface laryngeal electrode during electrophysiological monitoring were noted.

Conclusions: Recovery from profound rocuronium-induced block on the larynx is fast and complete with sugammadex. In urgent scenarios, "early" extubation can be performed, even with a TOF ratio ≤0.9. However, all procedures to prevent postoperative residual curarization should still be immediately undertaken.

Keywords: Laryngeal muscles; Neurophysiologic monitoring; Profound neuromuscular block; Sugammadex.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Androstanols / antagonists & inhibitors*
  • Androstanols / pharmacology
  • Anesthesia Recovery Period
  • Evoked Potentials, Motor / drug effects
  • Female
  • Humans
  • Laryngeal Nerves / drug effects*
  • Laryngeal Nerves / physiology
  • Male
  • Middle Aged
  • Monitoring, Physiologic / methods
  • Myography / methods
  • Neuromuscular Blockade / methods*
  • Neuromuscular Monitoring / methods
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors*
  • Neuromuscular Nondepolarizing Agents / pharmacology
  • Postoperative Care / methods
  • Prospective Studies
  • Recovery of Function / drug effects
  • Rocuronium
  • Sugammadex
  • Young Adult
  • gamma-Cyclodextrins / pharmacology*

Substances

  • Androstanols
  • Neuromuscular Nondepolarizing Agents
  • gamma-Cyclodextrins
  • Sugammadex
  • Rocuronium